BPC-157
BPC-157 (Body Protection Compound-157) is a 15-amino-acid fragment originally found in proteins from the human stomach lining. Most evidence comes from animal studies exploring wound healing, tendon repair, and gut health applications.
Verified sources for BPC-157
These vendors are vetted by PeptideWiki for purity testing and COA transparency.
Overview of BPC-157
Supports healing by reducing inflammation, improving blood-vessel repair signaling, and protecting the gut lining.
Promotes angiogenesis and tissue remodeling signals, supporting wound/tendon healing processes.
Improves fibroblast activity and collagen organization (proposed), which may aid soft-tissue repair.
Enhances mucosal defense and epithelial repair signaling, supporting ulcer healing and gut barrier recovery.
Modulates inflammatory damage in GI tissue, which may reduce irritation and speed recovery after injury.
Downshifts pro-inflammatory signaling (proposed), which may reduce local inflammation at injury sites.
Interacts with nitric oxide pathways (proposed), which may influence blood flow and healing response.
May modulate pain/injury signaling indirectly via inflammation reduction (proposed)
Read Full BPC-157 Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Injury, Repair & Recovery
UPDATE: FDA Picks 7 Peptides for July 2026 Reclassification Vote
The FDA will vote on reclassifying BPC-157, TB-500, KPV, MOTS-c, DSIP, Epitalon, and Semax for pharmacy compounding at the July 23-24 PCAC meeting.
BPC-157 & America's Drug Approval System
BPC-157 sits in a dead zone: too developed to dismiss, too underdeveloped to approve, too risky to invest in, too in demand to disappear. This piece explains how it got there and why it stays there.
Are Oral Peptides Here? Inside the Breakthrough and What's Next
Oral semaglutide just proved cardiovascular benefit, Eli Lilly cleared Phase 3, and a microneedle pill raised a billion dollars. Where the oral peptide era actually stands, and what it means for research peptides.
Oral vs Injectable Peptides: Bioavailability and Effectiveness
Oral peptides face massive bioavailability barriers, but real exceptions exist. We break down the evidence for oral semaglutide, BPC-157, collagen peptides, and emerging delivery tech.